AVORO CAPITAL ADVISORS LLC 13D and 13G filings for Amicus Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 09:31 am Sale |
2024-09-30 | 13G | Amicus Therapeutics, Inc. FOLD |
AVORO CAPITAL ADVISORS LLC | 23,175,000 7.800% |
-4,225,000 (-15.42%) |
Filing |
| 2024-02-14 09:22 am Purchase |
2023-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
AVORO CAPITAL ADVISORS LLC | 27,400,000 9.300% |
600,000 (+2.24%) |
Filing |
| 2023-02-14 09:35 am Purchase |
2022-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
AVORO CAPITAL ADVISORS LLC | 26,800,000 9.500% |
8,300,000 (+44.86%) |
Filing |
| 2022-02-11 10:05 am Purchase |
2021-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
AVORO CAPITAL ADVISORS LLC | 18,500,000 6.600% |
7,300,000 (+65.18%) |
Filing |